Product Wiki · Recalls · EU Safety Gate (RAPEX)

Puppe — recall 0162/08

EU Safety Gate (RAPEX) · Germany · 2008-02-08 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
0162/08
Date of alert
2008-02-08
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Beauty Girl
Product category
Toys
Product type
Doll
Reported risk: Das Produkt stellt ein chemisches Risiko dar, da es DEHP enthält. Der DEHP-Gehalt in den Spielzeugen überschreitet den zulässigen Grenzwert gemäß der Richtlinie zur Beschränkung chemischer Stoffe 76/769/EWG. Die Produkte stellen ein Gesundheitsrisiko für Kinder dar.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Voluntary withdrawal from the market and recall from consumers by the distributor
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Doll

Risk Description (original English): The product poses a chemical risk because it contains DEHP.The contents of DEHP in the toys exceed permitted limit laid down by the Chemicals Restrictions Directive 76/769/EEC. The products pose a risk for health of a child.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/-13220

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.